ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 9, September 2025 | pp. 789–795
DOI: 10.46882/AJIDR/148876
Article Type: Original Article
Title: Seroepidemiology and clinical outcomes of yellow fever virus infection during sylvatic-to-urban spillover surveillance
Names of Authors: Kwame Boateng¹*, Sophie Laurent², Rafael Silva³
Authors’ Affiliations: ¹Department of Virology, Noguchi Memorial Institute for Medical Research, Accra, Ghana. ²Emerging Arboviruses Unit, Pasteur Institute, Paris, France. ³Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.
Abstract: Yellow fever virus poses recurring epidemic threats when sylvatic transmission cycles spill over into unvaccinated peri-urban populations. We evaluated acute yellow fever incidence, neutralizing antibody levels, and clinical severity predictors among febrile jaundice patients. Serum samples from 350 suspected cases were tested via IgM capture enzyme-linked immunosorbent assay, plaque reduction neutralization testing, and reverse transcription polymerase chain reaction. Acute yellow fever was confirmed in 11.4 percent of patients, exclusively among unvaccinated individuals, with elevated aspartate aminotransferase and renal dysfunction predicting mortality. Catch-up fractional-dose vaccination campaigns and Aedes vector control are critical.
Keywords: Yellow fever virus, Arbovirus surveillance, Viral hemorrhagic fever, Immunization coverage, Flavivirus
Citation: Boateng K, Laurent S, Silva R (2025). Seroepidemiology and clinical outcomes of yellow fever virus infection during sylvatic-to-urban spillover surveillance. African Journal of Infectious Diseases Research, 12(9): 789–795. DOI: 10.46882/AJIDR/148876
Manuscript Timeline: Received: July 30, 2025; Revised: August 30, 2025; Accepted: September 11, 2025; Published: September 18, 2025
African Journal of Infectious Diseases Research | Vol. 12, No. 9, September 2025 | pp. 782–788
DOI: 10.46882/AJIDR/148875
Article Type: Research Article
Title: Prevalence, genetic diversity, and zoonotic transmission of Cryptosporidium parvum and Enterocytozoon bieneusi in HIV-infected adults with chronic diarrhea
Names of Authors: Tendai Moyo¹*, Soren Lindqvist²
Authors’ Affiliations: ¹Department of Medical Microbiology, University of Zimbabwe, Harare, Zimbabwe. ²Department of Parasitology, Uppsala University, Uppsala, Sweden.
Abstract: Opportunistic enteric microsporidia and coccidian parasites cause debilitating chronic diarrhea and wasting in severely immunocompromised HIV patients. We determined the prevalence and genotypes of Cryptosporidium species and Enterocytozoon bieneusi among HIV-positive adults presenting with persistent diarrhea. Stool specimens from 280 patients were analyzed via nested polymerase chain reaction targeting 18S rRNA and internal transcribed spacer loci. Cryptosporidium was identified in 20.4 percent and E. bieneusi in 14.6 percent of patients, predominantly among individuals with CD4 counts below 150 cells per microliter. Antiretroviral therapy optimization and safe drinking water access remain vital.
Keywords: Enterocytozoon bieneusi, Cryptosporidium, HIV/AIDS, Opportunistic diarrhea, Molecular genotyping
Citation: Moyo T, Lindqvist S (2025). Prevalence, genetic diversity, and zoonotic transmission of Cryptosporidium parvum and Enterocytozoon bieneusi in HIV-infected adults with chronic diarrhea. African Journal of Infectious Diseases Research, 12(9): 782–788. DOI: 10.46882/AJIDR/148875
Manuscript Timeline: Received: July 27, 2025; Revised: August 28, 2025; Accepted: September 09, 2025; Published: September 15, 2025
African Journal of Infectious Diseases Research | Vol. 12, No. 9, September 2025 | pp. 775–781
DOI: 10.46882/AJIDR/148874
Article Type: Clinical Study
Title: Etiology, clinical presentation, and mortality predictors of neonatal sepsis in a tertiary level-three neonatal intensive care unit
Names of Authors: Grace Okafor¹*, Hannah Bennett², Carlos Mendoza³
Authors’ Affiliations: ¹Department of Pediatrics, Lagos University Teaching Hospital, Lagos, Nigeria. ²Department of Neonatal Medicine, University of Bristol, Bristol, United Kingdom. ³Department of Pediatrics, University of Buenos Aires, Buenos Aires, Argentina.
Abstract: Neonatal sepsis remains a primary driver of newborn mortality, increasingly complicated by multidrug-resistant hospital-acquired pathogens. We evaluated early-onset and late-onset neonatal sepsis incidence, causative bacterial organisms, and antimicrobial susceptibility profiles. Blood cultures and inflammatory biomarkers from 465 suspected septic neonates were prospectively analyzed. Culture-confirmed sepsis occurred in 29.2 percent of infants, dominated by Klebsiella pneumoniae, Staphylococcus aureus, and Acinetobacter baumannii. Resistance to first-line ampicillin and gentamicin exceeded 72 percent among Gram-negative isolates, with prematurity and septic shock independently predicting mortality. Strengthening hand hygiene compliance and antimicrobial stewardship is essential.
Keywords: Neonatal sepsis, Klebsiella pneumoniae, Antimicrobial resistance, Neonatal intensive care, Bloodstream infection
Citation: Okafor G, Bennett H, Mendoza C (2025). Etiology, clinical presentation, and mortality predictors of neonatal sepsis in a tertiary level-three neonatal intensive care unit. African Journal of Infectious Diseases Research, 12(9): 775–781. DOI: 10.46882/AJIDR/148874
Manuscript Timeline: Received: July 24, 2025; Revised: August 25, 2025; Accepted: September 06, 2025; Published: September 12, 2025
African Journal of Infectious Diseases Research | Vol. 13, No. 9, September 2026 | pp. 628–635
DOI: 10.46882/AJIDR/148996
Article Type: Research Article
Title: Genomic characterization and neuraminidase inhibitor susceptibility of seasonal influenza A and B viruses in outpatients
Names of Authors: Ji-Hoon Kang¹*, Amara Diop², Stefan Richter³
Abstract: Seasonal influenza viruses undergo continuous antigenic drift and occasional antiviral resistance mutations, necessitating annual virological surveillance to inform vaccine formulation. We characterized circulating hemagglutinin clades and oseltamivir susceptibility among patients presenting with influenza-like illness. Nasopharyngeal swabs from 490 outpatients were tested via multiplex reverse transcription polymerase chain reaction and whole-genome sequencing. Influenza A H3N2 subclade 3C.2a1b predominated at 68.4 percent, while the H275Y neuraminidase mutation was detected in 1.4 percent of H1N1pdm09 isolates. Continuous genomic monitoring supports timely clinical antiviral guidance.
Keywords: Influenza virus, Antigenic drift, Oseltamivir resistance, Neuraminidase, Virological surveillance
Citation: Kang J, Diop A, Richter S (2026). Genomic characterization and neuraminidase inhibitor susceptibility of seasonal influenza A and B viruses in outpatients. African Journal of Infectious Diseases Research, 13(9): 628–635. DOI: 10.46882/AJIDR/148996
Manuscript Timeline: Received: July 22, 2026; Revised: August 21, 2026; Accepted: September 06, 2026; Published: September 12, 2026.
African Journal of Infectious Diseases Research | Vol. 12, No. 9, September 2025 | pp. 768–774
DOI: 10.46882/AJIDR/148873
Article Type: Research Article
Title: Molecular epidemiology and antifungal resistance profiles of Aspergillus species isolated from chronic pulmonary aspergillosis patients
Names of Authors: Thabo Mokoena¹*, Elena Fischer², Kenji Takahashi³
Authors’ Affiliations: ¹Department of Pulmonology, University of the Witwatersrand, Johannesburg, South Africa. ²Institute of Medical Microbiology, University of Cologne, Cologne, Germany. ³Department of Infectious Diseases, Nagasaki University, Nagasaki, Japan.
Abstract: Chronic pulmonary aspergillosis frequently complicates healed pulmonary tuberculosis cavities, leading to progressive hemoptysis and respiratory failure. We characterized Aspergillus species distribution, cyp51A azole resistance mutations, and triazole susceptibility among post-tuberculosis patients with persistent cavitary lesions. Sputum fungal cultures and serum Aspergillus-specific IgG testing were performed for 230 patients. Chronic pulmonary aspergillosis was diagnosed in 24.3 percent of participants, with Aspergillus fumigatus accounting for 69.6 percent of isolates and TR34/L98H azole resistance mutations identified in 12.5 percent. Integrating Aspergillus IgG serology into post-tuberculosis follow-up clinics improves timely diagnosis.
Keywords: Chronic pulmonary aspergillosis, Aspergillus fumigatus, Azole resistance, Post-tuberculosis lung disease, Medical mycology
Citation: Mokoena T, Fischer E, Takahashi K (2025). Molecular epidemiology and antifungal resistance profiles of Aspergillus species isolated from chronic pulmonary aspergillosis patients. African Journal of Infectious Diseases Research, 12(9): 768–774. DOI: 10.46882/AJIDR/148873
Manuscript Timeline: Received: July 21, 2025; Revised: August 22, 2025; Accepted: September 04, 2025; Published: September 09, 2025
African Journal of Infectious Diseases Research | Vol. 12, No. 9, September 2025 | pp. 761–767
DOI: 10.46882/AJIDR/148872
Article Type: Original Article
Title: Seroprevalence and risk factors of Hepatitis D virus co-infection among chronic Hepatitis B surface antigen carriers
Names of Authors: Amina Suleiman¹*, Lucas Moreau²
Authors’ Affiliations: ¹Department of Gastroenterology and Hepatology, Ahmadu Bello University, Zaria, Nigeria. ²Department of Virology, University of Lyon, Lyon, France.
Abstract: Hepatitis D virus co-infection accelerates liver fibrosis progression and hepatocellular carcinoma risk in individuals living with chronic hepatitis B. We evaluated anti-HDV seroprevalence, active HDV RNA viremia, and hepatic fibrosis severity among HBsAg-positive outpatients. Serum specimens from 420 chronic hepatitis B patients were screened via enzyme-linked immunosorbent assay and quantitative reverse transcription polymerase chain reaction. Anti-HDV antibodies were detected in 9.8 percent of participants, with active HDV RNA confirmed in 63.4 percent of seropositive cases and significantly elevated liver stiffness scores. Universal reflex anti-HDV screening for all HBsAg-positive patients is strongly recommended.
Keywords: Hepatitis D virus, Hepatitis B co-infection, Viral hepatitis, Liver cirrhosis, Seroprevalence
Citation: Suleiman A, Moreau L (2025). Seroprevalence and risk factors of Hepatitis D virus co-infection among chronic Hepatitis B surface antigen carriers. African Journal of Infectious Diseases Research, 12(9): 761–767. DOI: 10.46882/AJIDR/148872
Manuscript Timeline: Received: July 18, 2025; Revised: August 19, 2025; Accepted: September 01, 2025; Published: September 06, 2025